Mohamed M Khalifa

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Molecular Docking

Quality Control

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

Archiv der Pharmazie

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ashraf K El-Damasy, Hyun Ji Kim, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Mohamed M Khalifa, Eun-Kyoung Bang, Gyochang Keum
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Ashraf K El-Damasy, Hyun Ji Kim, Ahmed Ali Al-Karmalawy, Radwan Alnajjar, Mohamed M Khalifa, Eun-Kyoung Bang, Gyochang Keum
Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Abdulrahman M Saleh, Hazem A Mahdy, Mohamed Ayman El-Zahabi, Ahmed B M Mehany, Mohamed M Khalifa, Ibrahim H Eissa
Design, synthesis, in silico studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers. RSC advances 13 (32) (2023)
Mohammed Farrag El-Behairy, Walaa Hamada Abd-Allah, Mohamed M Khalifa, Mohamed S Nafie, Mohamed A Saleh, Mohammed S Abdel-Maksoud, Tarfah Al-Warhi, Wagdy M Eldehna, Ahmed Ali Al-Karmalawy
Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mohammed Farrag El-Behairy, Walaa Hamada Abd-Allah, Mohamed M Khalifa, Mohamed S Nafie, Mohamed A Saleh, Mohammed S Abdel-Maksoud, Tarfah Al-Warhi, Wagdy M Eldehna, Ahmed Ali Al-Karmalawy
Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Eslam B Elkaeed, Reda G Yousef, Mohamed M Khalifa, Albaraa Ibrahim, Ahmed B M Mehany, Ibraheem M M Gobaara, Bshra Ali A Alsfouk, Wagdy M Eldehna, Ahmed M Metwaly, Ibrahim H Eissa, Mohamed Ayman El-Zahabi
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules (Basel, Switzerland) 27 (19) (2022)
Mohammed S Taghour, Hazem A Mahdy, Maher H Gomaa, Ahmed Aglan, Mahmoud Gomaa Eldeib, Alaa Elwan, Mohammed A Dahab, Eslam B Elkaeed, Aisha A Alsfouk, Mohamed M Khalifa, Ibrahim H Eissa, Hazem Elkady
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Reda G Yousef, Albaraa Ibrahim, Mohamed M Khalifa, Wagdy M Eldehna, Ibraheem M M Gobaara, Ahmed B M Mehany, Eslam B Elkaeed, Aisha A Alsfouk, Ahmed M Metwaly, Ibrahim H Eissa
Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Eslam B Elkaeed, Mohamed M Khalifa, Bshra Ali A Alsfouk, Aisha A Alsfouk, Abdul-Aziz M M El-Attar, Ibrahim H Eissa, Ahmed M Metwaly
The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach. Metabolites 12 (11) (2022)
Mohamed Abdelwahab Abdelgawad, Khaled El-Adl, Sanadelaslam S A El-Hddad, Mostafa M Elhady, Nashwa M Saleh, Mohamed M Khalifa, Fathalla Khedr, Mohamed Alswah, AbdEIAziz A Nayl, Mohammed M Ghoneim, Nour E A Abd El-Sattar
Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Nashwa M Saleh, Adel A H Abdel-Rahman, Asmaa M Omar, Mohamed M Khalifa, Khaled El-Adl
Pyridine-derived VEGFR-2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking. Archiv der Pharmazie 354 (8) (2021)
Ibrahim H Eissa, Mohamed M Khalifa, Eslam B Elkaeed, Elsayed E Hafez, Aisha A Alsfouk, Ahmed M Metwaly
In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules (Basel, Switzerland) 26 (20) (2021)
Helmy Sakr, Rezk R Ayyad, Ali A El-Helby, Mohamed M Khalifa, Hazem A Mahdy
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors. Archiv der Pharmazie 354 (6) (2021)